Rinda Sama - Axonics Modulation Chief Officer
| AXNXDelisted Stock | USD 70.98 0.48 0.68% |
Executive
Mr. Rinda Sama is the Chief Operating Officer of the company. From May 2014 to August 2018, Mr. Sama served as our Vice President, Operations and Quality. From June 2011 to May 2014, Mr. Sama served as Director, Operations and Quality of Vessix Vascular, Inc since 2017.
| Age | 45 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Phone | 949 396 6322 |
| Web | https://www.axonics.com |
Rinda Sama Latest Insider Activity
Tracking and analyzing the buying and selling activities of Rinda Sama against Axonics Modulation stock is an integral part of due diligence when investing in Axonics Modulation. Rinda Sama insider activity provides valuable insight into whether Axonics Modulation is net buyers or sellers over its current business cycle. Note, Axonics Modulation insiders must abide by specific rules, including filing SEC forms every time they buy or sell Axonics Modulation'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Rinda Sama over three months ago Disposition of 3392 shares by Rinda Sama of Axonics Modulation at 56.53 subject to Rule 16b-3 |
Axonics Modulation Management Efficiency
Axonics Modulation's management efficiency ratios could be used to measure how well Axonics Modulation manages its routine affairs as well as how well it operates its assets and liabilities.Axonics Modulation Technologies currently holds 27.62 M in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Axonics Modulation has a current ratio of 10.28, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Axonics Modulation's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Marcee Maroney | Pulmonx Corp | 54 | |
| Kimberly Lockwood | CONMED | N/A | |
| Mark Ploof | Medtronic PLC | N/A | |
| John Webb | LivaNova PLC | N/A | |
| John Harris | Integer Holdings Corp | 64 | |
| Laurene Isip | Integra LifeSciences Holdings | N/A | |
| John Ferrell | CONMED | 56 | |
| Irene Thomas | Neuropace | 55 | |
| Olaf Hedrich | Medtronic PLC | N/A | |
| Susan Krause | Integra LifeSciences Holdings | N/A | |
| Mervin Smith | iRhythm Technologies | 49 | |
| Julie Dewey | Orthofix Medical | 63 | |
| Michael McBreen | Integra LifeSciences Holdings | 58 | |
| David Lehman | Pulmonx Corp | 63 | |
| Mathieu Aussermeier | Integra LifeSciences Holdings | N/A | |
| Leah Akin | Neuropace | N/A | |
| Gali Attias | Nano X Imaging | 45 | |
| Andres Cedron | Orthofix Medical | 43 | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Ruth Fleming | Integra LifeSciences Holdings | N/A | |
| Chad Patterson | iRhythm Technologies | 42 | |
Management Performance
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 |
Axonics Modulation Leadership Team
Elected by the shareholders, the Axonics Modulation's board of directors comprises two types of representatives: Axonics Modulation inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Axonics. The board's role is to monitor Axonics Modulation's management team and ensure that shareholders' interests are well served. Axonics Modulation's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Axonics Modulation's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alfred Ford, Chief Commercial Officer | ||
| Danny Dearen, Chief Operating and Financial Officer | ||
| MD MAS, Chief Officer | ||
| Raymond Cohen, CEO, Director | ||
| Rinda Sama, Chief Officer | ||
| JD Esq, General VP | ||
| Aaron Pettit, General Officer | ||
| Kari Keese, Chief Officer | ||
| John Woock, Chief Marketing Officer | ||
| Neil Bhalodkar, Vice Relations | ||
| Guangqiang Jiang, Chief Officer |
Axonics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Axonics Modulation a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0089 | ||||
| Return On Asset | -0.0063 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 3.32 B | ||||
| Shares Outstanding | 51.11 M | ||||
| Shares Owned By Insiders | 1.26 % | ||||
| Shares Owned By Institutions | 87.22 % | ||||
| Number Of Shares Shorted | 3.31 M | ||||
| Price To Earning | (10.68) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Global Correlations Find global opportunities by holding instruments from different markets |